1. Home
  2. CANF vs MWG Comparison

CANF vs MWG Comparison

Compare CANF & MWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$0.17

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Multi Ways Holdings Limited

MWG

Multi Ways Holdings Limited

HOLD

Current Price

$0.35

Market Cap

13.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
MWG
Founded
1994
1988
Country
Israel
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
13.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CANF
MWG
Price
$0.17
$0.35
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.25
N/A
AVG Volume (30 Days)
1.2M
14.1M
Earning Date
02-03-2026
12-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$560,000.00
$43,413,000.00
Revenue This Year
$461.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.48
52 Week Low
$0.17
$0.21
52 Week High
$2.33
$0.61

Technical Indicators

Market Signals
Indicator
CANF
MWG
Relative Strength Index (RSI) 22.66 84.02
Support Level $0.26 $0.25
Resistance Level $0.30 $0.26
Average True Range (ATR) 0.02 0.03
MACD -0.01 0.01
Stochastic Oscillator 3.41 42.16

Price Performance

Historical Comparison
CANF
MWG

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

About MWG Multi Ways Holdings Limited

Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.

Share on Social Networks: